128 related articles for article (PubMed ID: 31396884)
1. Genetic Changes of P
Shukla SK; Singh G; Shahi KS; Bhuvan ; Pant P
J Gastrointest Cancer; 2020 Jun; 51(2):552-559. PubMed ID: 31396884
[TBL] [Abstract][Full Text] [Related]
2. Histopathological Examination of Gallbladder Specimens in Kumaon Region of Uttarakhand.
Shukla SK; Pant P; Singh G; Bhuvan ; Shahi KS
J Gastrointest Cancer; 2020 Mar; 51(1):121-129. PubMed ID: 30847742
[TBL] [Abstract][Full Text] [Related]
3. A novel polymorphism in codon 25 of the KRAS gene associated with gallbladder carcinoma patients of the eastern part of India.
Pramanik V; Sarkar BN; Kar M; Das G; Malay BK; Sufia KK; Lakkakula BV; Vadlamudi RR
Genet Test Mol Biomarkers; 2011 Jun; 15(6):431-4. PubMed ID: 21375404
[TBL] [Abstract][Full Text] [Related]
4. Alterations of p53 gene in gallbladder cancer patients of North India.
Nigam P; Misra U; Negi TS; Mittal B; Choudhuri G
Trop Gastroenterol; 2010; 31(2):96-100. PubMed ID: 20862982
[TBL] [Abstract][Full Text] [Related]
5. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
Hanada K; Itoh M; Fujii K; Tsuchida A; Ooishi H; Kajiyama G
Cancer; 1996 Feb; 77(3):452-8. PubMed ID: 8630951
[TBL] [Abstract][Full Text] [Related]
6. [P53 gene mutation in gallbladder cancer].
Roa I; Melo A; Roa J; Araya J; Villaseca M; de Aretxabala X
Rev Med Chil; 2000 Mar; 128(3):251-8. PubMed ID: 10962865
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of K-ras codon 12 mutation in patients with resected gallbladder cancer.
Kazmi HR; Chandra A; Nigam J; Noushif M; Parmar D; Gupta V
Dig Surg; 2013; 30(3):233-9. PubMed ID: 23838952
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the RAS/RAF/MAP kinase pathway commonly occur in gallbladder adenomas but are uncommon in gallbladder adenocarcinomas.
Pai RK; Mojtahed K; Pai RK
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):133-40. PubMed ID: 21307665
[TBL] [Abstract][Full Text] [Related]
9. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
10. Sporadic TP53 transition mutations in chronic cholecystitis are possibly linked to gallbladder carcinogenesis.
Yanagisawa N; Yamashita K; Kuba T; Okayasu I
Anticancer Res; 2010 Nov; 30(11):4443-9. PubMed ID: 21115891
[TBL] [Abstract][Full Text] [Related]
11. Tumor Protein p53 and K-ras Gene Mutations in Peruvian Patients with Gallbladder Cancer.
Vidaurre T; Casavilca S; Montenegro P; Gomez H; Calderón M; Navarro J; Aramburu J; Poquioma E; Tsuchiya Y; Asai T; Ajioka Y; Sato A; Ikoma T; Nakamura K
Asian Pac J Cancer Prev; 2019 Jan; 20(1):289-294. PubMed ID: 30678452
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations involved in the development of gallbladder carcinomas from Greek patients.
Saetta A; Lazaris AC; Michalopoulos NV; Davaris PS
Hepatogastroenterology; 2001; 48(41):1284-8. PubMed ID: 11677947
[TBL] [Abstract][Full Text] [Related]
13. Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer.
Singh MK; Chetri K; Pandey UB; Kapoor VK; Mittal B; Choudhuri G
J Gastroenterol Hepatol; 2004 Aug; 19(8):916-21. PubMed ID: 15242496
[TBL] [Abstract][Full Text] [Related]
14. Mutation profiling in gallbladder cancer in Indian population.
Kumari N; Corless CL; Warrick A; Beadling C; Nelson D; Neff T; Krishnani N; Kapoor VK
Indian J Pathol Microbiol; 2014; 57(1):9-12. PubMed ID: 24739824
[TBL] [Abstract][Full Text] [Related]
15. IL-33 overexpression in gallbladder cancers associated with pancreatobiliary maljunction.
Tomioka Y; Sung YN; Sawada R; Hong SM; Akita M; Itoh T; Ajiki T; Fukumoto T; Zen Y
Histopathology; 2019 Sep; 75(3):365-375. PubMed ID: 30882917
[TBL] [Abstract][Full Text] [Related]
16. Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations.
Salmaninejad A; Ghadami S; Dizaji MZ; Golchehre Z; Estiar MA; Zamani MR; Ebrahimzadeh-Vesal R; Nowroozi MR; Shakoori A
Clin Lab; 2015; 61(7):749-59. PubMed ID: 26299074
[TBL] [Abstract][Full Text] [Related]
17. A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population.
Kazmi HR; Chandra A; Kumar S; Satyam LK; Gupta A; Nigam J; Srivastava M; Mittal B
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2577-2583. PubMed ID: 27620744
[TBL] [Abstract][Full Text] [Related]
18. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder.
Fujii K; Yokozaki H; Yasui W; Kuniyasu H; Hirata M; Kajiyama G; Tahara E
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):461-6. PubMed ID: 8781743
[TBL] [Abstract][Full Text] [Related]
19. High frequency of TP53 but not K-ras gene mutations in Bolivian patients with gallbladder cancer.
Asai T; Loza E; Roig GV; Ajioka Y; Tsuchiya Y; Yamamoto M; Nakamura K
Asian Pac J Cancer Prev; 2014; 15(13):5449-54. PubMed ID: 25041017
[TBL] [Abstract][Full Text] [Related]
20. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas.
Wistuba II; Miquel JF; Gazdar AF; Albores-Saavedra J
Hum Pathol; 1999 Jan; 30(1):21-5. PubMed ID: 9923922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
